Retrospective analysis examines maternal outcomes, postpartum hemorrhage, and anesthesia in patients with congenital heart disease, suggesting significant implications for care.
( Int J Obstet Anesth . 2024;60:104241. DOI: 10.1016/j.ijoa.2024.104241) As medical advancements have enabled more congenital heart disease (CHD) patients to become pregnant, managing these patients during the peripartum period remains complex due to significant cardiovascular changes that occur during pregnancy, labor, and delivery. These changes increase the risk of heart failure, arrhythmia, stroke, and maternal mortality, with heart disease remaining a leading cause of maternal death in the United Kingdom and the United States. This retrospective study, conducted at Rabin Medical Center, Beilinson Hospital in Israel, investigates the anesthetic management, postpartum hemorrhage (PPH) incidence, and maternal outcomes in patients with CHD delivering between 2009 and 2023. The study focuses on the role of anesthesiologists in managing CHD patients, emphasizing neuraxial analgesia and cesarean delivery (CD) anesthesia while addressing complications such as PPH.
No takes yet. Share an insight, caveat, or question.
Iluz‐Freundlich et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: